Companies/Profound Medical Corp.

Company profile

Profound Medical Corp.

NASDAQ: PROF · Healthcare · Medical - Devices

Canadian filerHQ Mississauga, ONCIK 0001628808Reports USD

#575 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

44D

FH 57DQ 22GM —SS 56

v0.1 · 55/100 weight · provisional

↑ balance-sheet leverage, Altman-Z · ↓ disclosure history, listing tenure

Methodology →

Revenue TTM

$18.7M

Rev growth YoY (TTM)

+33.8%

Net income (FY)

-$42.6M

Employees

142

Market cap

$206.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$16.1M$16.1M2025

Net income-$42.6M-$42.6M2025

Operating income-$41.3M-$41.3M2025

Total assets$77.5M$77.5M2025

Liabilities$11.0M$11.0M2025

Equity$66.4M$66.4M2025

Revenue trend

FY2024 – FY2025 · USD

$5.9M

FY24

$9.7M

FY24

$16.1M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Recurring - Non-Capital60%

Capital Equipment40%

By geography

UNITED STATES76%

CANADA19%

GERMANY5%

The read

Profound Medical Corp. booked $16.1M in FY2025 revenue, growing 65% year over year — faster than most Healthcare companies we track, at a -264.4% net margin.

Peers · Healthcare

KORU Medical Systems, Inc.72B Arcturus Therapeutics Holdings Inc.49D InfuSystem Holdings, Inc.80B+Whitehawk Therapeutics Inc50D

Key facts

CEOArun Swarup Menawat

SectorHealthcare

IndustryMedical - Devices

HeadquartersMississauga, ON

ExchangeNASDAQ: PROF

Employees142

IPO date2019-10-29

Latest filings

8-K2026-05-15 8-K2026-05-14 10-Q2026-05-07 8-K2026-05-07 8-K2026-04-16 8-K2026-04-14 8-K2026-04-01 8-K2026-03-27

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.